Eli Lilly and Company, Retatrutide, TRIUMPH-2, Obesity, Type 2 Diabetes, A1C Reduction, Weight Loss, Phase 3 Clinical Trial, GIP

Indianapolis, Indiana, U.S., September 29, 2026 Eli Lilly and Company has announced detailed Phase 3 TRIUMPH-2 results showing that...